Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2033
2.3 Market Size & Forecast, By Segmentation, 2022–2033
2.3.1 Market Size By Type
2.3.2 Market Size By Technology
2.3.3 Market Size By Application
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Regulatory & Reimbursement Statistics
4.1.1 Number of approved drugs and therapies in precision medicine annually %
4.1.2 Average approval time for precision therapies (months or years) %
4.1.3 Reimbursement coverage rates by region or country %
4.1.4 Policy initiatives driving adoption (tax incentives, grants) %
4.2 Treatment & Therapy Metrics
4.2.1 Average duration of targeted therapies per patient %
4.2.2 Success or response rates for specific therapies (oncology, rare diseases) %
4.2.3 Market share of emerging therapies vs. established therapies %
4.2.4 Patient adherence rates to genomic-based treatments %
4.3 Ecosystem & Strategic Engagement Metrics
4.3.1 Number of public-private collaborations for precision medicine initiatives %
4.3.2 Volume of strategic partnerships between pharma, diagnostics, and hospitals %
4.3.3 Annual investment in infrastructure and precision medicine centers %
4.3.4 Policy-driven pilot programs and regional incentive adoption %
4.4 Research & Clinical Trials Metrics
4.4.1 Number of ongoing clinical trials for precision therapies by region %
4.4.2 Number of patients enrolled in genomic or personalized medicine trials %
4.4.3 Success rate of clinical trials (% reaching approval) %
4.4.4 Emerging clinical trial initiatives and collaborations %
5. Precision Medicine Market Segmental Analysis & Forecast, By Type, 2022 – 2033, Value (USD Billion)
5.1 Introduction
5.2 Targeted Therapy
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Genomic Medicine
5.4 Pharmacogenomics
5.5 Companion Diagnostics
5.6 Others
6. Precision Medicine Market Segmental Analysis & Forecast, By Technology, 2022 – 2033, Value (USD Billion)
6.1 Introduction
6.2 Next-Generation Sequencing (NGS)
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 PCR & qPCR
6.4 CRISPR
6.5 Bioinformatics
6.6 Others
7. Precision Medicine Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Billion)
7.1 Introduction
7.2 Oncology
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Cardiovascular diseases
7.4 Rare & Genetic Disorders
7.5 Neurological Disorders
7.6 Others
8. Precision Medicine Market Segmental Analysis & Forecast, By End User, 2022 – 2033, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Diagnostic Laboratories
8.4 Research Institutes
8.5 Pharmaceutical & Biotech Companies
9. Precision Medicine Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Precision Medicine Market Size & Forecast, By Type, 2022 – 2033
9.2.3 Precision Medicine Market Size & Forecast, By Technology, 2022 – 2033
9.2.4 Precision Medicine Market Size & Forecast, By Application, 2022 – 2033
9.2.5 Precision Medicine Market Size & Forecast, By End User, 2022 – 2033
9.2.6 Precision Medicine Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Precision Medicine Market Size & Forecast, By Type, 2022 – 2033
9.3.3 Precision Medicine Market Size & Forecast, By Technology, 2022 – 2033
9.3.4 Precision Medicine Market Size & Forecast, By Application, 2022 – 2033
9.3.5 Precision Medicine Market Size & Forecast, By End User, 2022 – 2033
9.3.6 Precision Medicine Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Precision Medicine Market Size & Forecast, By Type, 2022 – 2033
9.4.3 Precision Medicine Market Size & Forecast, By Technology, 2022 – 2033
9.4.4 Precision Medicine Market Size & Forecast, By Application, 2022 – 2033
9.4.5 Precision Medicine Market Size & Forecast, By End User, 2022 – 2033
9.4.6 Precision Medicine Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Precision Medicine Market Size & Forecast, By Type, 2022 – 2033
9.5.3 Precision Medicine Market Size & Forecast, By Technology, 2022 – 2033
9.5.4 Precision Medicine Market Size & Forecast, By Application, 2022 – 2033
9.5.5 Precision Medicine Market Size & Forecast, By End User, 2022 – 2033
9.5.6 Precision Medicine Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Precision Medicine Market Size & Forecast, By Type, 2022 – 2033
9.6.3 Precision Medicine Market Size & Forecast, By Technology, 2022 – 2033
9.6.4 Precision Medicine Market Size & Forecast, By Application, 2022 – 2033
9.6.5 Precision Medicine Market Size & Forecast, By End User, 2022 – 2033
9.6.6 Precision Medicine Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2033
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Technology Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Technology Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Illumina
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Thermo Fisher Scientific
10.6.3 Roche
10.6.4 Pfizer
10.6.5 Novartis
10.6.6 AstraZeneca
10.6.7 Johnson & Johnson
10.6.8 Merck & Co.
10.6.9 Abbott Laboratories
10.6.10 Medtronic
10.6.11 Qiagen
10.6.12 Guardant Health
10.6.13 Myriad Genetics
10.6.14 Foundation Medicine
10.6.15 Tempus Labs
10.6.16 Caris Life Sciences
10.6.17 Exact Sciences
10.6.18 Agilent Technologies
10.6.19 Siemens Healthineers
10.6.20 23andMe
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
